Sabine Lagger
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Correction: Cell‑autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53‑driven senescence and confers an immune‑active tumor microenvironment.
Journal: Molecular cancer
Published: July 07, 2026
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment.
Journal: Molecular cancer
Published: March 17, 2024
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
Journal: Molecular cancer
Published: November 29, 2023
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Journal: Molecular cancer
Published: March 23, 2023
KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis.
Journal: Molecular cancer
Published: December 27, 2021
DNA hypomethylation leads to cGAS-induced autoinflammation in the epidermis.
Journal: The EMBO journal
Published: March 13, 2021
A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells.
Journal: Blood
Published: January 25, 2021
Analysis of Methylation Dynamics Reveals a Tissue-Specific, Age-Dependent Decline in 5-Methylcytosine Within the Genome of the Vertebrate Aging Model Nothobranchius furzeri.
Journal: Frontiers in molecular biosciences
Published: November 08, 2020
Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis.
Journal: Life science alliance
Published: May 25, 2020
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer.
Journal: Molecular systems biology
Published: September 19, 2019
Last Updated: 09/26/2026